Jafron Biomedical Co.Ltd(300529)
Management measures for the assessment of the implementation of stock option incentive plan in 2022
In order to ensure the smooth implementation of the stock option incentive plan of Jafron Biomedical Co.Ltd(300529) (hereinafter referred to as “the company”) in 2022, further improve the corporate governance structure, form a good and balanced value distribution system, encourage the directors, senior managers, middle managers and core backbone personnel of the company to work honestly and diligently, and ensure the steady improvement of the company’s performance, To ensure the realization of the company’s development strategy and business objectives, these measures are formulated in accordance with relevant national regulations and the actual situation of the company.
1、 Assessment purpose
Further improve the corporate governance structure, establish and improve the company’s incentive and restraint mechanism, ensure the smooth implementation of the equity incentive plan, give full play to the role of equity incentive to the greatest extent, comprehensively improve the overall quality of employees, provide basis for employees’ promotion, promotion, reward and punishment, and promote the common growth of the company and employees, So as to ensure the realization of the company’s development strategy and business objectives.
2、 Assessment principle
The assessment and evaluation must adhere to the principles of fairness, openness and fairness, and evaluate in strict accordance with these measures and the performance of the assessment objects, so as to realize the close combination of the equity incentive plan with the work performance and contribution of the incentive objects, so as to improve the management performance and maximize the interests of the company and all shareholders.
3、 Assessment scope
The measures are applicable to all incentive objects participating in the company’s incentive plan, including but not limited to directors, senior managers, middle managers and core backbone working in the company (including branches and holding subsidiaries).
4、 Assessment organization
The remuneration and assessment committee of the board of directors of the company is responsible for leading and organizing the assessment work and assessing the incentive objects.
5、 Performance evaluation indicators and standards
(I) performance assessment requirements at the company level
The exercise assessment year of stock options granted in the incentive plan is three fiscal years from 2022 to 2024, and the performance assessment is carried out annually. The company level performance assessment score (x) is determined by the score and weight of each assessment index, and the company level exercise proportion coefficient (m) of the current year is determined according to the company level performance assessment score (x).
The annual performance assessment requirements for the first granted stock option are as follows:
Score of exercise (x): 0, 50, 75, 100 performance evaluation indicators are arranged
50% in 2022, the company’s operating revenue is not less than a ＜ 3.29 billion yuan ≤ a 3.42 billion yuan ≤ a a ≥ 3.57 billion yuan, less than 3.57 billion yuan (a) ＜ 3.42 billion yuan ＜ 3.57 billion yuan
30% in 2023, the company’s operating revenue is not a ＜ 4.46 billion yuan ≤ a 4.64 billion yuan ≤ a a ≥ 4.88 billion yuan, less than 4.88 billion yuan (a) ＜ 4.64 billion yuan ＜ 4.88 billion yuan
20% in 2024, the company’s operating revenue is not less than a ＜ 6.05 billion yuan ≤ a 6.2 billion yuan ≤ a ＜ a ≥ 6.36 billion yuan, less than 6.36 billion yuan (a) ＜ 6.2 billion yuan and 6.36 billion yuan
Note: the above indicators are subject to the audited annual data of the company.
If the stock option reserved for grant is granted in 2022, the annual performance assessment requirements are the same as those of the stock option granted for the first time.
If the reserved stock options are granted in 2023, the performance assessment requirements for each year are as follows:
Score of exercise (x): 0, 50, 75, 100 performance evaluation indicators are arranged
50% in 2023, the company’s operating revenue is not a ＜ 4.46 billion yuan ≤ a 4.64 billion yuan ≤ a a ≥ 4.88 billion yuan, less than 4.88 billion yuan (a) ＜ 4.64 billion yuan ＜ 4.88 billion yuan
50% in 2024, the company’s operating revenue is not less than a ＜ 6.05 billion yuan ≤ a 6.2 billion yuan ≤ a ＜ a ≥ 6.36 billion yuan, less than 6.36 billion yuan (a) ＜ 6.2 billion yuan and 6.36 billion yuan
Note: the above indicators are subject to the audited annual data of the company.
The company level exercise proportion coefficient (m) corresponding to the company level performance assessment score (x) is shown in the following table:
Company level performance assessment score (x) company level exercise proportion coefficient (m)
X = 0 points 0%
X = 50 points 50%
X = 75 points 75%
X = 100 points 100%
(II) performance appraisal requirements at individual level
The individual level assessment of the incentive object shall be organized and implemented in accordance with the relevant provisions of the company’s current salary and assessment, and the comprehensive assessment results of the incentive object in each assessment year shall be scored, as shown in the following table:
Individual evaluation results are excellent, good, qualified and unqualified
Individual level exercise proportion coefficient (P) 100% 80% 65% 50% 0%
The actual exercise amount of the incentive object in the current year = the planned exercise amount of the incentive object in the current year × Company level exercise proportion coefficient (m) × Exercise proportion coefficient at individual level (P).
The stock options that cannot be exercised by the incentive object in the year of assessment shall be cancelled by the company.
6、 Assessment period and times
(I) assessment period
The fiscal year before the incentive object exercises the stock option.
(II) assessment times
The stock option incentive plan shall be assessed once a year.
7、 Assessment procedure
The human resources department of the company is responsible for the specific assessment work under the guidance of the remuneration and assessment committee of the board of directors. At the end of each year, the company’s human resources department organizes the assessment with the participation of the company’s leaders and relevant departments according to the factors such as work attitude, work efficiency, work quality and work contribution, and saves the assessment results, On this basis, a performance appraisal report shall be formed and submitted to the remuneration and appraisal committee of the board of directors.
8、 Assessment result management
(I) feedback and appeal of assessment results
The appraisee has the right to know his own appraisal results. The employee’s direct supervisor shall notify the appraisee of the appraisal results within 5 working days after the appraisal. All departments shall timely put forward improvement direction and opinions for the personnel with poor assessment results through assessment, and timely persuade the unqualified personnel to retreat. If the appraisee has any objection to his / her appraisal results, he / she can communicate with the human resources department for settlement. If it cannot be solved through communication, the assessed object can appeal to the human resources department, which shall review and determine the final assessment result or grade within 10 working days. (II) filing of assessment results
After the assessment, the assessment results shall be archived and saved as confidential data.
9、 Supplementary Provisions
(I) the board of directors is responsible for formulating, interpreting and revising these measures.
(II) these measures have been deliberated and approved by the general meeting of shareholders of the company and will be implemented after the equity incentive plan takes effect.
Jafron Biomedical Co.Ltd(300529) board of directors January 17, 2022
